Recurrent Quality of Life
In recurrent GBM,
Optune Gio™ monotherapy demonstrated efficacy comparable to that of chemotherapy1,*
Quality of life: Overall results
- No clinically meaningful differences were found in global health and social functioning
- Data collected by EORTC QLQ-C30 questionnaire
*Therapy options were the physician's best choice for chemotherapy. The best available therapy was prescribed according to local practice and depending on prior treatment exposure.
Learn about Optune Gio’s safety profile in recurrent GBM
EORTC QLQ-C30, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30; GBM, glioblastoma.
Reference: 1. Stupp R, Wong ET, Kanner AA, et al. NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer. 2012;48(14):2192-2202.